(Q45368289)

English

Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges

scientific article published on 13 March 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

post-transplant lymphoproliferative disorder

0 references

Epstein–Barr virus

0 references

author name string

N A Kittan

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

F Beier

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

K Kurz

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

H H Niller

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

L Egger

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

W Jilg

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

R Andreesen

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

E Holler

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

G C Hildebrandt

9

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

publication date

13 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

524-530

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Spectrum of Epstein-Barr virus-associated diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Epstein-Barr virus and the nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Epstein-Barr virus meningoencephalitis with a lymphoma-like response in an immunocompetent host

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Primary central nervous system post-transplant lymphoproliferative disorder presenting as cerebral hemorrhage after unrelated bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Central nervous system post-transplant lymphoproliferative disorder despite negative serum and spinal fluid Epstein-Barr virus DNA PCR.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Donor lymphocyte transfusion for the treatment of Epstein-Barr virus-associated lymphoproliferative disorder of the brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Failure to detect Epstein-Barr virus (EBV) DNA in plasma by real-time PCR in a case of EBV-associated posttransplantation lymphoproliferative disorder confined to the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

High fatality rate of Epstein-Barr virus-associated lymphoproliferative disorder occurring after bone marrow transplantation with rabbit antithymocyte globulin conditioning regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Brainstem encephalitis resulting from Epstein-Barr virus mimicking an infiltrating tumor in a child.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Psychiatric symptoms and cognitive dysfunction caused by Epstein-Barr virus-induced encephalitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Encephalitis caused by Epstein-Barr virus in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Neuroimaging of herpesvirus infections in children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Use of PCR for the diagnosis of herpesvirus infections of the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Quantitation of Epstein-Barr virus mRNA using reverse transcription and real-time PCR.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Treatment of Epstein-Barr-virus-associated primary CNS B cell lymphoma with allogeneic T-cell immunotherapy and stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Isolated central nervous system posttransplant lymphoproliferative disorder treated with high-dose intravenous methotrexate.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

How I treat EBV lymphoproliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2011.00621.X

21 January 2018

Identifiers

10.1111/J.1399-3062.2011.00621.X

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45368289&oldid=2075906777"